Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Email this article to a friend

The protein C pathway: implications for the design of the RESPOND study

Burkhard Vangerow*, Andrew F Shorr, Duncan Wyncoll, Jonathan Janes, David R Nelson and Konrad Reinhart

Critical Care 2007, 11(Suppl 5):S4 doi:10.1186/cc6155

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.